-
1
-
-
49049122193
-
Alzheimer's disease and vascular dementia in developing countries: Prevalence, management, and risk factors
-
Kalaria RN, Maestre GE, Arizaga R, Friedland RP, Galasko D, Hall K, et al. Alzheimer's disease and vascular dementia in developing countries: Prevalence, management, and risk factors. Lancet Neurol 2008; 7: 812-826.
-
(2008)
Lancet Neurol
, vol.7
, pp. 812-826
-
-
Kalaria, R.N.1
Maestre, G.E.2
Arizaga, R.3
Friedland, R.P.4
Galasko, D.5
Hall, K.6
-
2
-
-
29144508843
-
Global prevalence of dementia: A delphi consensus study
-
Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M, et al. Global prevalence of dementia: A delphi consensus study. Lancet 2005; 366: 2112-2117.
-
(2005)
Lancet
, vol.366
, pp. 2112-2117
-
-
Ferri, C.P.1
Prince, M.2
Brayne, C.3
Brodaty, H.4
Fratiglioni, L.5
Ganguli, M.6
-
3
-
-
33749015483
-
Update on hypertension and Alzheimer's disease
-
Skoog I, Gustafson D. Update on hypertension and Alzheimer's disease. Neurol Res 2006; 28: 605-611.
-
(2006)
Neurol Res
, vol.28
, pp. 605-611
-
-
Skoog, I.1
Gustafson, D.2
-
4
-
-
79955697004
-
Neurovascular coupling in cognitive impairment associated with diabetes mellitus
-
Mogi M, Horiuchi M. Neurovascular coupling in cognitive impairment associated with diabetes mellitus. Circ J 2011; 75: 1042-1048.
-
(2011)
Circ J
, vol.75
, pp. 1042-1048
-
-
Mogi, M.1
Horiuchi, M.2
-
5
-
-
12444326206
-
Hypertension and cognitive function. Blood pressure regulation and cognitive function: A review of the literature
-
Papademetriou V. Hypertension and cognitive function. Blood pressure regulation and cognitive function: A review of the literature. Geriatrics 2005; 60: 20-24.
-
(2005)
Geriatrics
, vol.60
, pp. 20-24
-
-
Papademetriou, V.1
-
6
-
-
0034994528
-
Antihypertensive drugs and incidence of dementia: The Rotterdam study
-
in't Veld BA, Ruitenberg A, Hofman A, Stricker BH, Breteler MM. Antihypertensive drugs and incidence of dementia: The Rotterdam study. Neurobiol Aging 2001; 22: 407-412.
-
(2001)
Neurobiol Aging
, vol.22
, pp. 407-412
-
-
Veld, B.A.1
Ruitenberg, A.2
Hofman, A.3
Stricker, B.H.4
Breteler, M.M.5
-
7
-
-
33646433026
-
Antihypertensive medication use and incident alzheimer disease: The Cache County Study
-
Khachaturian AS, Zandi PP, Lyketsos CG, Hayden KM, Skoog I, Norton MC, et al. Antihypertensive medication use and incident alzheimer disease: The Cache County Study. Arch Neurol 2006; 63: 686-692.
-
(2006)
Arch Neurol
, vol.63
, pp. 686-692
-
-
Khachaturian, A.S.1
Zandi, P.P.2
Lyketsos, C.G.3
Hayden, K.M.4
Skoog, I.5
Norton, M.C.6
-
8
-
-
0037078284
-
Preservation of cognitive function with antihypertensive medications: A longitudinal analysis of a community-based sample of African Americans
-
Murray MD, Lane KA, Gao S, Evans RM, Unverzagt FW, Hall KS, et al. Preservation of cognitive function with antihypertensive medications: A longitudinal analysis of a community-based sample of African Americans. Arch Intern Med 2002; 162: 2090-2096.
-
(2002)
Arch Intern Med
, vol.162
, pp. 2090-2096
-
-
Murray, M.D.1
Lane, K.A.2
Gao, S.3
Evans, R.M.4
Unverzagt, F.W.5
Hall, K.S.6
-
9
-
-
0032816804
-
Occurrence and progression of dementia in a community population aged 75 years and older: Relationship of antihypertensive medication use
-
Guo Z, Fratiglioni L, Zhu L, Fastbom J, Winblad B, Viitanen M. Occurrence and progression of dementia in a community population aged 75 years and older: Relationship of antihypertensive medication use. Arch Neurol 1999; 56: 991-996.
-
(1999)
Arch Neurol
, vol.56
, pp. 991-996
-
-
Guo, Z.1
Fratiglioni, L.2
Zhu, L.3
Fastbom, J.4
Winblad, B.5
Viitanen, M.6
-
11
-
-
70450045976
-
Angiotensins in Alzheimer's disease: Friend or foe
-
Kehoe PG, Miners S, Love S. Angiotensins in Alzheimer's disease: Friend or foe? Trends Neurosci 2009; 32: 619-628.
-
(2009)
Trends Neurosci
, vol.32
, pp. 619-628
-
-
Kehoe, P.G.1
Miners, S.2
Love, S.3
-
12
-
-
33847791727
-
Is inhibition of the renin-angiotensin system a new treatment option for Alzheimer's disease?
-
Kehoe PG, Wilcock GK. Is inhibition of the renin-angiotensin system a new treatment option for Alzheimer's disease? Lancet Neurol 2007; 6: 373-378.
-
(2007)
Lancet Neurol
, vol.6
, pp. 373-378
-
-
Kehoe, P.G.1
Wilcock, G.K.2
-
13
-
-
84868286859
-
The association between hypertension and dementia in the elderly
-
Igase M, Kohara K, Miki T. The association between hypertension and dementia in the elderly. Int J Hypertens 2012; 2012: 320648.
-
(2012)
Int J Hypertens 2012
, pp. 320648
-
-
Igase, M.1
Kohara, K.2
Miki, T.3
-
14
-
-
40149086837
-
Effects of antihypertensive drug treatment on the risk of dementia and cognitive impairment
-
Poon IO. Effects of antihypertensive drug treatment on the risk of dementia and cognitive impairment. Pharmacotherapy 2008; 28: 366-375.
-
(2008)
Pharmacotherapy
, vol.28
, pp. 366-375
-
-
Poon, I.O.1
-
15
-
-
79952773620
-
Angiotensin II receptor blockers and risk of cancer in patients with systemic hypertension
-
Huang CC, Chan WL, Chen YC, Chen TJ, Lin SJ, Chen JW, et al. Angiotensin II receptor blockers and risk of cancer in patients with systemic hypertension. Am J Cardiol 2011; 107: 1028-1033.
-
(2011)
Am J Cardiol
, vol.107
, pp. 1028-1033
-
-
Huang, C.C.1
Chan, W.L.2
Chen, Y.C.3
Chen, T.J.4
Lin, S.J.5
Chen, J.W.6
-
16
-
-
0038387463
-
Taiwan's new national health insurance program: Genesis and experience so far
-
Cheng TM. Taiwan's new national health insurance program: Genesis and experience so far. Health Aff (Millwood) 2003; 22: 61-76.
-
(2003)
Health Aff (Millwood)
, vol.22
, pp. 61-76
-
-
Cheng, T.M.1
-
17
-
-
73349097900
-
Angiotensin receptor blocker prevented Beta-amyloid-induced cognitive impairment associated with recovery of neurovascular coupling
-
Takeda S, Sato N, Takeuchi D, Kurinami H, Shinohara M, Niisato K, et al. Angiotensin receptor blocker prevented Beta-amyloid-induced cognitive impairment associated with recovery of neurovascular coupling. Hypertension 2009; 54: 1345-1352.
-
(2009)
Hypertension
, vol.54
, pp. 1345-1352
-
-
Takeda, S.1
Sato, N.2
Takeuchi, D.3
Kurinami, H.4
Shinohara, M.5
Niisato, K.6
-
18
-
-
77956904820
-
Of fads, fashion, surrogate endpoints and dual RAS blockade
-
Messerli FH, Staessen JA, Zannad F. Of fads, fashion, surrogate endpoints and dual RAS blockade. Eur Heart J 2010; 31: 2205-2208.
-
(2010)
Eur Heart J
, vol.31
, pp. 2205-2208
-
-
Messerli, F.H.1
Staessen, J.A.2
Zannad, F.3
-
19
-
-
50849089332
-
Telmisartan prevented cognitive decline partly due to PPAR-gamma activation
-
Mogi M, Li JM, Tsukuda K, Iwanami J, Min LJ, Sakata A, et al. Telmisartan prevented cognitive decline partly due to PPAR-gamma activation. Biochem Biophys Res Commun 2008; 375: 446-449.
-
(2008)
Biochem Biophys Res Commun
, vol.375
, pp. 446-449
-
-
Mogi, M.1
Li, J.M.2
Tsukuda, K.3
Iwanami, J.4
Min, L.J.5
Sakata, A.6
-
20
-
-
84861598856
-
Effects of valsartan, an angiotensin II receptor blocker, on coronary atherosclerosis in patients with acute myocardial infarction who receive an angiotensin-converting enzyme inhibitor
-
Yano H, Hibi K, Nozawa N, Ozaki H, Kusama I, Ebina T, et al. Effects of valsartan, an angiotensin II receptor blocker, on coronary atherosclerosis in patients with acute myocardial infarction who receive an angiotensin-converting enzyme inhibitor. Circ J 2012; 76: 1442-1451.
-
(2012)
Circ J
, vol.76
, pp. 1442-1451
-
-
Yano, H.1
Hibi, K.2
Nozawa, N.3
Ozaki, H.4
Kusama, I.5
Ebina, T.6
-
21
-
-
74949131237
-
Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: Prospective cohort analysis
-
Li NC, Lee A, Whitmer RA, Kivipelto M, Lawler E, Kazis LE, et al. Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: Prospective cohort analysis. BMJ 2010; 340: b5465.
-
(2010)
BMJ
, vol.340
-
-
Li, N.C.1
Lee, A.2
Whitmer, R.A.3
Kivipelto, M.4
Lawler, E.5
Kazis, L.E.6
-
22
-
-
80054843547
-
Associations of anti-hypertensive treatments with Alzheimer's disease, vascular dementia, and other dementias
-
Davies NM, Kehoe PG, Ben-Shlomo Y, Martin RM. Associations of anti-hypertensive treatments with Alzheimer's disease, vascular dementia, and other dementias. J Alzheimers Dis 2011; 26: 699-708.
-
(2011)
J Alzheimers Dis
, vol.26
, pp. 699-708
-
-
Davies, N.M.1
Kehoe, P.G.2
Ben-Shlomo, Y.3
Martin, R.M.4
-
23
-
-
0037534905
-
The study on cognition and prognosis in the elderly (SCOPE): Principal results of a randomized double-blind intervention trial
-
Lithell H, Hansson L, Skoog I, Elmfeldt D, Hofman A, Olofsson B, et al. The study on cognition and prognosis in the elderly (SCOPE): Principal results of a randomized double-blind intervention trial. J Hypertens 2003; 21: 875-886.
-
(2003)
J Hypertens
, vol.21
, pp. 875-886
-
-
Lithell, H.1
Hansson, L.2
Skoog, I.3
Elmfeldt, D.4
Hofman, A.5
Olofsson, B.6
-
24
-
-
51449085994
-
Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the prevention regimen for effectively avoiding second strokes (PRoFESS) trial: A double-blind, active and placebo-controlled study
-
Diener HC, Sacco RL, Yusuf S, Cotton D, Ounpuu S, Lawton WA, et al. Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the prevention regimen for effectively avoiding second strokes (PRoFESS) trial: A double-blind, active and placebo-controlled study. Lancet Neurol 2008; 7: 875-884.
-
(2008)
Lancet Neurol
, vol.7
, pp. 875-884
-
-
Diener, H.C.1
Sacco, R.L.2
Yusuf, S.3
Cotton, D.4
Ounpuu, S.5
Lawton, W.A.6
-
25
-
-
78650022206
-
Reninangiotensin system blockade and cognitive function in patients at high risk of cardiovascular disease: Analysis of data from the ONTARGET and TRANSCEND studies
-
Anderson C, Teo K, Gao P, Arima H, Dans A, Unger T, et al. Reninangiotensin system blockade and cognitive function in patients at high risk of cardiovascular disease: Analysis of data from the ONTARGET and TRANSCEND studies. Lancet Neurol 2011; 10: 43-53.
-
(2011)
Lancet Neurol
, vol.10
, pp. 43-53
-
-
Anderson, C.1
Teo, K.2
Gao, P.3
Arima, H.4
Dans, A.5
Unger, T.6
-
26
-
-
74949089743
-
Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia
-
McGuinness B, Todd S, Passmore P, Bullock R. Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia. Cochrane Database Syst Rev 2009; (4): CD004034.
-
(2009)
Cochrane Database Syst Rev
, vol.4
-
-
McGuinness, B.1
Todd, S.2
Passmore, P.3
Bullock, R.4
-
27
-
-
79551499769
-
Placebocontrolled trials of blood pressure-lowering therapies for primary prevention of dementia
-
Staessen JA, Thijs L, Richart T, Odili AN, Birkenhager WH. Placebocontrolled trials of blood pressure-lowering therapies for primary prevention of dementia. Hypertension 2011; 57: e6-e7.
-
(2011)
Hypertension
, vol.57
-
-
Staessen, J.A.1
Thijs, L.2
Richart, T.3
Odili, A.N.4
Birkenhager, W.H.5
-
28
-
-
33644641866
-
Evidence-based usefulness of Ca antagonists and ACEIs and ARBs for the primary and secondary prevention of major cardiovascular and renal events in patients with hypertension
-
(in Japanese)
-
Fujino T, Hasebe N, Kikuchi K. Evidence-based usefulness of Ca antagonists and ACEIs and ARBs for the primary and secondary prevention of major cardiovascular and renal events in patients with hypertension Clin Calcium 2005; 15: 1695-1708 (in Japanese).
-
(2005)
Clin Calcium
, vol.15
, pp. 1695-1708
-
-
Fujino, T.1
Hasebe, N.2
Kikuchi, K.3
-
29
-
-
80053123344
-
Incident dementia in a defined older Chinese population
-
Chen R, Hu Z, Wei L, Ma Y, Liu Z, Copeland JR. Incident dementia in a defined older Chinese population. PLoS One 2011; 6: e24817.
-
(2011)
PLoS One
, vol.6
-
-
Chen, R.1
Hu, Z.2
Wei, L.3
Ma, Y.4
Liu, Z.5
Copeland, J.R.6
|